Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis

The host restriction factor Apobec3G is a cytidine deaminase that incorporates into HIV-1 virions and interferes with viral replication. The HIV-1 accessory protein Vif subverts Apobec3G by targeting it for proteasomal degradation. We studied the Apobec3G homomerisation and the interaction of Apobec3G with Vif in detail.

We used the MAPPIT two-hybrid technique to analyse the Apobec3G-Apobec3G and the Apobec3G-Vif interactions in intact human cells. MAPPIT is based on the functional complementation of a cytokine receptor signalling pathway.

We propose a model in which Apobec3G N-terminal domains symmetrically interact via a head-to-head interface containing residues 122 RLYYFW 127. Mutations in the head-to-head interface abrogate the Apobec3G-Apobec3G interaction. All mutations that inhibit Apobec3G-Apobec3G binding also inhibit the Apobec3G-Vif interaction, indicating that the head-to head interface plays an important role in the interaction with Vif. Only the D128K, P129A and T32Q mutations specifically affect the Apobec3G-Vif association. In our model, D128, P129 and T32 cluster at the edge of the head-to-head interface, possibly forming a Vif binding site composed of two Apobec3G molecules.

We propose that Vif either binds directly at the Apobec3G head-to-head interface or associates with an RNA-stabilized Apobec3G oligomer.

Affiliations

1. University of Ghent, Ghent, Belgium

   • Delphine Lavens
   • , Frank Peelman
   • , José Van der Heyden
   • , Isabel Uyttendaele
   • , Dominiek Catteeuw
   •  & Jan Tavernier

2. VIB, Ghent, Belgium

   • Delphine Lavens
   • , Frank Peelman
   • , José Van der Heyden
   • , Isabel Uyttendaele
   • , Dominiek Catteeuw
   •  & Jan Tavernier

3. TIBOTEC, Mechelen, Belgium

   • Bertrand Van Schouwbroeck
   • , Julia Kurth
   • , Sabine Hallenberger
   •  & Reginald Clayton

Corresponding author

Correspondence to Delphine Lavens.

Reprints and Permissions